Matsumoto S
Department of Physiology, Nippon Dental University, School of Dentistry at Tokyo, Japan.
J Pharmacol Exp Ther. 1997 Apr;281(1):531-9.
The effect of vagally and acetylcholine (ACh)-induced bronchoconstrictions was assessed by an increase in the slowly adapting pulmonary stretch receptor (SAR) activity during both inflation and deflation and the rise in total lung resistance (R(L)). Those responses were compared before and after pirenzepine (PZ, M1 selective) with or without propranolol (a beta adrenoreceptor blocker), gallamine (M2 selective), 4-DAMP (M3 selective), hexamethonium (C6, a ganglion blocker) and atropine (a nonselective muscarinic receptor antagonist). The SAR activity was recorded from the cut left vagus nerve, whereas the right vagus nerve was cut and stimulated electrically. Experiments were performed in anesthetized, artificially ventilated rabbits. Vagal stimulation (5-20 Hz, 13 V, 0.2 msec) for 30 sec and ACh injection (1 and 3 microg/kg) caused bronchoconstriction in a frequency- and dose-dependent manner. At the treatment with PZ (3-30 microg/kg) in both propranolol-untreated and -treated animals, vagally mediated bronchoconstriction was blocked by this M1 receptor blocker at 10 microg/kg, whereas ACh-induced bronchoconstriction was not significantly altered by any dose of PZ. Gallamine (3-30 microg/kg) had no significant effect on vagally and ACh-induced bronchoconstrictions, which were completely blocked by atropine (2 mg/kg). Three micrograms of 4-DAMP augmented the SAR and R(L) responses to vagal stimulation but inhibited those responses to ACh injection. 4-DAMP at 10 to 30 microg/kg dose-dependently inhibited both vagally and ACh-induced bronchoconstrictions. C6 (20 mg/kg) abolished vagally mediated bronchoconstriction but had no significant effect on ACh-induced bronchoconstriction. These results suggest that M1 receptors function as the excitatory receptors in the rabbit airway.
通过在充气和放气过程中慢适应性肺牵张感受器(SAR)活性的增加以及总肺阻力(R(L))的升高来评估迷走神经和乙酰胆碱(ACh)诱导的支气管收缩效应。在给予哌仑西平(PZ,M1选择性拮抗剂)之前和之后,分别联合或不联合普萘洛尔(一种β肾上腺素能受体阻滞剂)、加拉明(M2选择性拮抗剂)、4-二甲基氨基吡啶(4-DAMP,M3选择性拮抗剂)、六甲铵(C6,一种神经节阻滞剂)和阿托品(一种非选择性毒蕈碱受体拮抗剂),比较这些反应。SAR活性通过切断左侧迷走神经记录,而右侧迷走神经切断后进行电刺激。实验在麻醉、人工通气的兔身上进行。迷走神经刺激(5 - 20Hz,13V,0.2毫秒)30秒和注射ACh(1和3微克/千克)以频率和剂量依赖的方式引起支气管收缩。在未用普萘洛尔处理和已用普萘洛尔处理的动物中,给予PZ(3 - 30微克/千克)治疗时,10微克/千克的这种M1受体阻滞剂可阻断迷走神经介导的支气管收缩,而任何剂量的PZ对ACh诱导的支气管收缩均无显著影响。加拉明(3 - 30微克/千克)对迷走神经和ACh诱导的支气管收缩均无显著影响,而阿托品(2毫克/千克)可完全阻断这两种收缩。3微克的4-DAMP增强了对迷走神经刺激的SAR和R(L)反应,但抑制了对注射ACh的反应。10至30微克/千克剂量的4-DAMP剂量依赖性地抑制迷走神经和ACh诱导的支气管收缩。C6(20毫克/千克)消除了迷走神经介导的支气管收缩,但对ACh诱导的支气管收缩无显著影响。这些结果表明M1受体在兔气道中起兴奋性受体的作用。